Urogen Pharma Bl007
Research payments
$221,515
Through program year 2022, $221,515 in research payments was reported against Urogen Pharma Bl007, across 139 payments, paid by Urogen Pharma, Inc..
- Paid by
- Urogen Pharma, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $65,225 | 48 |
| 2021 | Research | $156,290 | 91 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alexander Sankin New York, NY Named on 21 payments
- William Huang New York, NY Named on 12 payments
- K Chevli Cheektowaga, NY Named on 12 payments
- Ahmad Shabsigh Columbus, OH Named on 11 payments
- Hristos Kaimakliotis Indianapolis, IN Named on 10 payments
- Jay Raman Hershey, PA Named on 10 payments
- Phillip Pierorazio Philadelphia, PA Named on 10 payments
- Neal Shore Myrtle Beach, SC Named on 9 payments
- Brian Hu Loma Linda, CA Named on 7 payments
- Karim Chamie Los Angeles, CA Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.